NCT06530225View on ClinicalTrials.gov

Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescribing Surveillance Program

Not yet recruitingOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

April 30, 2029

Study Completion Date

April 30, 2030

Conditions
HIV Prevention
Interventions
OTHER

Education and Mentoring for Prescribing Pharmacists

Pharmacists enrolled in the PrEP prescribing cohort will receive implicit bias, health disparity and health equity training for HIV prevention. In addition, the pharmacists will receive mentorship and receive an implementation toolkit on best practices for PrEP prescribing.

Trial Locations (1)

70125

Xavier University of Louisiana, New Orleans

All Listed Sponsors
collaborator

Louisiana Public Health Institute

OTHER

lead

Xavier University of Louisiana.

OTHER

NCT06530225 - Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescribing Surveillance Program | Biotech Hunter | Biotech Hunter